SANG vs THRY
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
SANG exhibits severe financial fragility, highlighted by a weak Piotroski F-Score of 2/9 and a bearish technical trend of 0/100. While the stock appears cheap on a Price-to-Book (0.56) and Price-to-Sales (0.64) basis, these metrics are overshadowed by a -13% YoY revenue decline and consistent lack of profitability. Liquidity is a concern with a current ratio of 0.87, suggesting the company may struggle to meet short-term obligations. The combination of shrinking top-line growth and poor fundamental health indicates a classic value trap scenario.
THRY exhibits a stable but mediocre Piotroski F-Score of 4/9, indicating a lack of strong financial momentum. The stock is trading at a significant premium to its Graham Number ($1.06) and Intrinsic Value ($0.07), suggesting a severe disconnect between market price and fundamental value. While the forward P/E of 2.22 suggests an expected earnings surge, this is contradicted by stagnant revenue growth (2.7%) and razor-thin profit margins (0.04%). The long-term price trajectory is disastrous, with an 87.5% decline over five years.
Compare Another Pair
Related Comparisons
SANG vs THRY: Head-to-Head Comparison
This page compares Sangoma Technologies Corporation (SANG) and Thryv Holdings, Inc. (THRY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.